Dermaliq Therapeutics Signs USD 15 Million Series A Round to A...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
WILMINGTON, Del., Jan. 18, 2022 /PRNewswire-AsiaNet/ -- - Dermaliq Therapeutics, Inc. is an independent private pharmaceutical company emerged from Novaliq- Spin-off to unlock value in the space of medical dermatology by using Novaliq's transformative technology outside eye care- 3E Bioventures...
Authors: LATEST ASIANET NEWS RELEASES